Cargando…
Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells
Endocrine sensitivity, assessed by the expression of estrogen receptor (ER), has long been the predict factor to guide therapeutic decisions. Tamoxifen has been the most successful hormonal treatment in endocrine-sensitive breast cancer. However, in estrogen-insensitive cancer tamoxifen showed less...
Autores principales: | Wang, Kai-Lee, Hsia, Shih-Min, Yeh, Jiun-Yih, Cheng, Shao-Chi, Wang, Paulus S., Wang, Shyi-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694052/ https://www.ncbi.nlm.nih.gov/pubmed/23840656 http://dx.doi.org/10.1371/journal.pone.0067297 |
Ejemplares similares
-
Anti-Proliferative Effects of Evodiamine in Human Lung Cancer Cells
por: Hong, Ji-Young, et al.
Publicado: (2014) -
Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells
por: Zhong, Zhang-Feng, et al.
Publicado: (2015) -
Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis
por: Hu, Che-Yuan, et al.
Publicado: (2023) -
Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein
por: Wang, Shengpeng, et al.
Publicado: (2014) -
Effect of Evodiamine on Collagen-Induced Platelet Activation and Thrombosis
por: Yang, Xiaona, et al.
Publicado: (2022)